Health Trials

M-TEER

2

Review clinical trials related to M-TEER. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.

Participants needed: 21,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Montreal Heart InstituteUpdated: Oct 9, 2025Locations: 15
Eligibility criteria

five to ten image volumes at cardiac phases from 5% to 95% R-R [+7]

For TAVI group: Valve-in-valve procedures [+4]

Read more
Status: Not yet recruiting

Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy

A multi-centre, prospective, observational pilot registry in patients undergoing mitral valve repair for severe functional mitral regurgitation to report the heart failure drug therapy and dosing before the mitral valve procedure and afterwards to assess whether the recommended maximal dose of medication is administered. This maximal dose, although recommended, might not be tolerated well by patients and can cause side-effects. Researchers will determine whether the mitral valve repair procedure might have a possible effect on increasing the drug therapy towards the recommended optimal doses.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institut für Pharmakologie und Präventive MedizinUpdated: May 23, 2025Locations: 1Duration: 12 Months
Eligibility criteria

mitral transcatheter edge-to-edge repair (M-TEER) patients treated with the PASC... [+3]

Degenerative mitral regurgitation [+6]

Read more